Polymyositis Medication Savings with TheDrugClub
Last updated
Members can check active-formulary eligibility and membership pricing for Polymyositis medications. A condition association alone does not establish coverage.
What Is Polymyositis?
Polymyositis is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Polymyositis with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Pharmacist insight
Bisphosphonates for osteoporosis must be taken on an empty stomach with a full glass of water, and patients should remain upright for 30 minutes afterward. This prevents esophageal irritation. Generic alendronate is equally effective as brand-name Fosamax for preventing fractures.
Angela C. Beverly, PharmD
About Polymyositis
Polymyositis is a rare, chronic inflammatory disease that causes muscle weakness, often impacting daily life. While there's no cure, effective treatments can help manage symptoms and improve quality of life. TheDrugClub offers a valuable solution to help individuals and families afford the ongoing prescription medications needed for polymyositis, making treatment more accessible.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What is Polymyositis?
Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (drug toxicity); connective tissue diseases; infections; malignant neoplasms; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
Also called: Multiple Myositis
Classified under: Myositis
Source: Medical Subject Headings (MeSH), U.S. National Library of Medicine
Capitalization of MeSH cross-references in this definition was adjusted for readability. The U.S. National Library of Medicine does not endorse this change.
This information is educational and is not medical advice.